These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19483145)

  • 1. Efficient and effective compound management to support lead optimization.
    Johnson CW; Chatterjee M; Kubala S; Helm D; Houston J; Banks M
    J Biomol Screen; 2009 Jun; 14(5):523-30. PubMed ID: 19483145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case study: technology initiative led to advanced lead optimization screening processes at Bristol-Myers Squibb, 2004-2009.
    Zhang L; Cvijic ME; Lippy J; Myslik J; Brenner SL; Binnie A; Houston JG
    Drug Discov Today; 2012 Jul; 17(13-14):733-40. PubMed ID: 22425710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving lead generation success through integrated methods: transcending 'drug discovery by numbers'.
    Campbell JB
    IDrugs; 2010 Dec; 13(12):874-9. PubMed ID: 21154146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound management beyond efficiency.
    Burr I; Winchester T; Keighley W; Sewing A
    J Biomol Screen; 2009 Jun; 14(5):485-91. PubMed ID: 19502566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovation leading the way: application of lean manufacturing to sample management.
    Allen M; Wigglesworth MJ
    J Biomol Screen; 2009 Jun; 14(5):515-22. PubMed ID: 19483142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-quality cost-effective compound management support for HTS.
    Zaragoza-Sundqvist M; Eriksson H; Rohman M; Greasley PJ
    J Biomol Screen; 2009 Jun; 14(5):509-14. PubMed ID: 19487769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portfolio management in early stage drug discovery - a traveler's guide through uncharted territory.
    Betz UA
    Drug Discov Today; 2011 Jul; 16(13-14):609-18. PubMed ID: 21600301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and implementation of an automated compound management system in support of lead optimization.
    Quintero C; Kariv I
    J Biomol Screen; 2009 Jun; 14(5):499-508. PubMed ID: 19487770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound scale-up at the discovery-development interface.
    Nikitenko AA
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):729-40. PubMed ID: 17117683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Best practices in compound management for preserving compound integrity and accurately providing samples for assays.
    Matson SL; Chatterjee M; Stock DA; Leet JE; Dumas EA; Ferrante CD; Monahan WE; Cook LS; Watson J; Cloutier NJ; Ferrante MA; Houston JG; Banks MN
    J Biomol Screen; 2009 Jun; 14(5):476-84. PubMed ID: 19483144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case study: impact of technology investment on lead discovery at Bristol-Myers Squibb, 1998-2006.
    Houston JG; Banks MN; Binnie A; Brenner S; O'Connell J; Petrillo EW
    Drug Discov Today; 2008 Jan; 13(1-2):44-51. PubMed ID: 18190863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the most important approach in current drug discovery: doing the right things or doing things right?
    Elebring T; Gill A; Plowright AT
    Drug Discov Today; 2012 Nov; 17(21-22):1166-9. PubMed ID: 22569181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PGVL Hub: An integrated desktop tool for medicinal chemists to streamline design and synthesis of chemical libraries and singleton compounds.
    Peng Z; Yang B; Mattaparti S; Shulok T; Thacher T; Kong J; Kostrowicki J; Hu Q; Na J; Zhou JZ; Klatte D; Chao B; Ito S; Clark J; Sciammetta N; Coner B; Waller C; Kuki A
    Methods Mol Biol; 2011; 685():295-320. PubMed ID: 20981530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardized workflows for increasing efficiency and productivity in discovery stage bioanalysis.
    Bateman KP; Cohen L; Emary B; Pucci V
    Bioanalysis; 2013 Jul; 5(14):1783-94. PubMed ID: 23862710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in improving the quality and flexibility of compound management.
    Janzen WP; Popa-Burke IG
    J Biomol Screen; 2009 Jun; 14(5):444-51. PubMed ID: 19483148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ask the experts: the challenges and benefits of flow chemistry to optimize drug development.
    Anderson N; Gernaey KV; Jamison TF; Kircher M; Wiles C; Leadbeater NE; Sandford G; Richardson P
    Future Med Chem; 2012 Sep; 4(14):1779-89. PubMed ID: 23043475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Process optimization using combinatorial design principles: parallel synthesis and design of experiment methods.
    Gooding OW
    Curr Opin Chem Biol; 2004 Jun; 8(3):297-304. PubMed ID: 15183328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unbalanced portfolio.
    Federsel HJ
    Drug News Perspect; 2009 Jun; 22(5):287-92. PubMed ID: 19609466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deploying continuous improvement across the drug discovery value chain.
    Walker SM; Davies BJ
    Drug Discov Today; 2011 Jun; 16(11-12):467-71. PubMed ID: 21443967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.